Announcements and Notices - [Other - Miscellaneous]

Luye Pharma Group Ltd focuses on the research and development, production, and sales of pharmaceutical drugs for orthopedics, neurology, gastroenterology, and hepatology. The Company also sells active ingredients, R&D results, and patents of new drugs, as well as providing research services on a contractual basis.

Voluntary Announcement
Increase In Shareholding In The Company
By Controlling Shareholder

Announcements and Notices - [Overseas Regulatory Announcement - Issue of Securities and Related Matters]

Overseas Regulatory Announcement

Announcements and Notices - [Issue of Convertible Securities / Issue of Shares under a General Mandate]

Completion Of The Issue Of Us$50,000,000 5.85 Per Cent.
Convertible Bonds Due 2025

Announcements and Notices - [Other - Business Update]

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Luye Pharma (2186 HK)

Voluntary Announcement Increase In Shareholding In The Company By Controlling Shareholder

Overseas Regulatory Announcement

Completion Of The Issue Of Us$50,000,000 5.85 Per Cent. Convertible Bonds Due 2025

Voluntary Announcement Approval Of Zepzelca (Lurbinectedin For Injection) For Marketing In Mainland China

Voluntary Announcement - Ruoxinlin And Other Drugs Included On China'S 2024 National Reimbursement Drug List

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)